D.A. Davidson & Co’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

D.A. Davidson & Co’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1	Closed	-$2.04K	–	1478
2024 Q3	$2.04K	Hold	1	–	–	﹤0.01%	1373
2024 Q2	$1.66K	Buy	+1	New	+$90	﹤0.01%	1361

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

D.A. Davidson & Co's XBI Position: Q2 2026 in Review

D.A. Davidson & Co increased its State Street SPDR S&P Biotech ETF (XBI) stake by 139% in Q2 2026, buying an estimated $1.53M and bringing the position to 19,409 shares worth $3.07M. The position accounts for 0.02% of the portfolio, ranked #596.

D.A. Davidson & Co first reported a position in XBI in Q4 2016 and has held it in 39 quarters since. The position peaked at $4.02M in Q1 2024. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

D.A. Davidson & Co held 19,409 shares of State Street SPDR S&P Biotech ETF worth $3.07M as of Q2 2026.
D.A. Davidson & Co bought 11,281 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $1.53M.
State Street SPDR S&P Biotech ETF made up 0.02% of D.A. Davidson & Co's portfolio in Q2 2026, its #596 holding.
D.A. Davidson & Co first reported a position in State Street SPDR S&P Biotech ETF in Q4 2016 and has held it in 39 quarters since.
D.A. Davidson & Co's State Street SPDR S&P Biotech ETF position peaked at $4.02M in Q1 2024.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on D.A. Davidson & Co's 13F filing for Q2 2026, filed 24 Jul 2026.